EX-21.1 6 mrkr-20231231xex21d1.htm EX-21.1

Exhibit 21.1

SUBSIDIARIES

Marker Cell Therapy, Inc.

​

GeneMax Pharmaceuticals, Inc.

​

GeneMax Pharmaceuticals Canada, Inc.